Edgewise Therapeutics, Inc. · NASDAQ:EWTX
Koch Kevin sold 17,971 Edgewise Therapeutics, Inc. shares (Form 4)
Traded Aug 12, 2026 · Filed Aug 14, 2026
On Aug 12, 2026, Koch Kevin (Director, President and CEO) sold 17,971 Edgewise Therapeutics, Inc. shares at an average US$43.68 for US$785K, leaving 52,488 shares. Filed Aug 14, 2026 (Form 4).
- Sold
- 17,971 shares
- Price
- US$43.68 average (US$43.64 to US$44.33)
- Value
- US$785K
- Holding after
- 52,488 shares
- Trading plan
- No
- Role
- Director, President and CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 12, 2026 | Common Stock | Option exercise | 17,969 | 48,584 | Direct | |
| Aug 12, 2026 | Common Stock | Option exercise | 21,875 | 70,459 | Direct | |
| Aug 12, 2026 | Common Stock | Sale | 8,782 | US$43.64 | 61,677 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 8,276 | US$43.66 | 53,401 | Direct |
| Aug 12, 2026 | Common Stock | Sale | 913 | US$44.33 | 52,488 | Direct |